Indeed, previous studies show that patients with full mutation FXS can express low levels of FMR1 mRNA17, suggesting that hypermethylation may be incomplete18; however, the extent to which transcription occurs has not been analyzed in a systematically validated and reproducible assay. This evidence concerns the gene FMR1 and fragile X syndrome.